The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology.


Journal

European journal of heart failure
ISSN: 1879-0844
Titre abrégé: Eur J Heart Fail
Pays: England
ID NLM: 100887595

Informations de publication

Date de publication:
02 2019
Historique:
received: 19 07 2018
revised: 14 10 2018
accepted: 27 10 2018
pubmed: 3 1 2019
medline: 22 5 2019
entrez: 3 1 2019
Statut: ppublish

Résumé

The vast majority of acute heart failure episodes are characterized by increasing symptoms and signs of congestion with volume overload. The goal of therapy in those patients is the relief of congestion through achieving a state of euvolaemia, mainly through the use of diuretic therapy. The appropriate use of diuretics however remains challenging, especially when worsening renal function, diuretic resistance and electrolyte disturbances occur. This position paper focuses on the use of diuretics in heart failure with congestion. The manuscript addresses frequently encountered challenges, such as (i) evaluation of congestion and clinical euvolaemia, (ii) assessment of diuretic response/resistance in the treatment of acute heart failure, (iii) an approach towards stepped pharmacologic diuretic strategies, based upon diuretic response, and (iv) management of common electrolyte disturbances. Recommendations are made in line with available guidelines, evidence and expert opinion.

Identifiants

pubmed: 30600580
doi: 10.1002/ejhf.1369
doi:

Substances chimiques

Diuretics 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

137-155

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL103931
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

© 2019 The Authors. European Journal of Heart Failure © 2019 European Society of Cardiology.

Auteurs

Wilfried Mullens (W)

Ziekenhuis Oost Limburg, Genk, Belgium.
University of Hasselt, Hasselt, Belgium.

Kevin Damman (K)

University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Veli-Pekka Harjola (VP)

Emergency Medicine, University of Helsinki, Helsinki University Hospital, Helsinki, Finland.

Alexandre Mebazaa (A)

University of Paris Diderot, Hôpitaux Universitaires Saint Louis Lariboisière, APHP, U 942 Inserm, F-CRIN INI-CRCT, Paris, France.

Hans-Peter Brunner-La Rocca (HP)

Maastricht University Medical Center, Maastricht, The Netherlands.

Pieter Martens (P)

Ziekenhuis Oost Limburg, Genk, Belgium.
University of Hasselt, Hasselt, Belgium.

Jeffrey M Testani (JM)

Yale University, New Haven, CT, USA.

W H Wilson Tang (WHW)

Cleveland Clinic, Cleveland, OH, USA.

Francesco Orso (F)

University of Florence, Florence, Italy.

Patrick Rossignol (P)

Université de Lorraine, Inserm, Centre d'Investigations Clinique 1433 and Inserm U1116; CHRU Nancy; F-CRIN INI-CRCT, Nancy, France.

Marco Metra (M)

University of Brescia, Brescia, Italy.

Gerasimos Filippatos (G)

National and Kapodistrian University of Athens, Athens, Greece.
University of Cyprus, Nicosia, Cyprus.

Petar M Seferovic (PM)

University of Belgrade, Faculty of Medicine, Belgrade, Serbia.

Frank Ruschitzka (F)

UniversitätsSpital Zürich, Zürich, Switzerland.

Andrew J Coats (AJ)

IRCCS, San Raffaele Pisana, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH